Search

everythinglearnresearchcommunity

for

Search:↓

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Yellow and orange colors are important for diagnosing certain skin conditions.

Looking at skin can help find and treat serious diseases early.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Dermoscopy now helps diagnose various skin, hair, and nail issues, improving patient care and treatment understanding.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Lupus can cause hair loss and nail changes, with treatments available for both.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

Malassezia folliculitis mainly affects the trunk in males and is better detected with d-PAS staining.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Different treatments for alopecia areata have unpredictable results and varying success rates.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.